LongAPGEJun 2026
Apogee Therapeutics Inc.
AbbVie agreed to acquire Apogee Therapeutics for $135.11 per share in cash. The transaction values the biotechnology company at approximately $10 billion. The position is an…
APGE
Which hedge funds are long APGE?
1 published idea on Apogee Therapeutics Inc. across 1 fund — 1 long and 0 short.
Apogee Therapeutics hedge fund investment theses
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Apogee Therapeutics: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.